Iovance Biotherapeutics, Inc. (IOVA)
IOVA price $14.62 -0.24 -1.62%
- Ticker
- IOVA
- Price
- $14.62
- Change
- -0.24 -1.62%
- Market cap
- $6.62B
- P/E
- -20.36
- Forward P/E
- 60.67
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 47
Iovance Biotherapeutics, Inc., a biotechnology firm currently in the clinical development stage, is committed to discovering and bringing to market cancer immunotherapy solutions. Its core mission involves leveraging the patient's own immune system to effectively combat and eradicate cancerous cells. The company is presently conducting six Phase 2 clinical trials. These include study C-144-01, evaluating its primary…